text.skipToContent text.skipToNavigation
Pharma & Biotech

D-PASMC – Diseased Human Pulmonary Artery Smooth Muscle Cells – Diabetes Type II

Catalog #: CC-2913

D-PASMC, Pulmonary Artery Smooth Muscle Cells, Diabetes T2

Compare
AMP

Product Overview

Pulmonary artery smooth muscle cells are isolated from human donors that have been diagnosed with diabetes type I or type II disease. Further donor information, including medications, BMI, and disease duration may be obtained by contacting Lonza scientific support.     

Diseased cells are grown in the same optimized media system as normal human pulmonary artery smooth muscle cells.  Diabetic PASMC cultures can be used for experimental applications in diabetic-related cardiovascular pharmaceutical development, vascular pathology, including atherosclerosis.

CloneticsTM D-PASMC diseased human pulmonary artery smooth muscle cells and media are convenient and easy to use, allowing the researcher to focus on results.Cryopreserved CloneticsTM PASMC are shipped in third passage. Proliferating CloneticsTM PASMC are shipped in fourth passage. CloneticsTM cells, medium and reagents are quality tested together and guaranteed to give optimum performance as a complete cell system.

Content & Storage

Content

1 x Cryopreserved Ampule with ≥500,000 cells/vial

Instructions

Safety Data Sheets (SDS)

Certificate of Analysis (CoA)

Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.

Subscribe to our eNewsletter

Keep up to speed on the latest scientific developments, events, tips and tools from Lonza.

Interested in our Webinars?

Need a break from your daily routine? Grab a coffee and check out our free webinars. 

Need a Quote or Any Support?

Are Lonza's primary cells and media applicable to your project? Do you need a quote or any help? Contact us and a local representative will get back to you.

We use cookies to deliver the best service to you. By continuing to browse the site, you are agreeing to our use of cookies.Ok